000			03405cam a2200409Ii 4500
001			96101
003			ES-MaUEC
005			20230102112738.0
006			m o d
007			cr cnu|||unuuu
008			170601s2017 sz ob 000 0 eng d
020			_a3319575341
020			_a331957535X _q(electronic bk.)
020			_a9783319575346
020			_a9783319575353 _q(electronic bk.)
020			_z9783319575346
040			_aN$T _cN$T _dEBLCP _dN$T _dGW5XE _dUAB _dYDX _dESU _dAZU _dUPM _dOCLCF _dIOG _dOCLCA _dCOO _dVT2 _dSTF _dOCLCO _dMERER _dOCLCQ _dOHI _dOCLCO _dOCLCQ _dJG0 _dOCLCO _dOCLCA _dU3W _dES-MaUEC _bspa
050		4	_aQP572.O74 _bB443 2017 EB
245	0	0	_aBehavioral neuroscience of Orexin/Hypocretin _cAndrew J. Lawrence, Luis de Lecea, editors.
264		1	_aCham, Switzerland _bSpringer _c[2017]
300			_a1 recurso en línea
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_atext file _bPDF
490	0		_aCurrent topics in behavioral neurosciences _v33
500			_aSpringerLink _bSpringer Biomedical and Life Sciences eBooks 2017 English+International
504			_aIncluye referencias bibliográficas
505	0		_aThe Human Orexin/Hypocretin Receptor Crystal Structures -- Orexin/Hypocretin Signaling -- Orexin/Hypocretin and Organizing Principles for a Diversity of Wake-Promoting Neurons in the Brain -- The Hypocretin/Orexin Neuronal Networks in Zebrafish -- Hypocretins and Arousal -- Orexin OX 2 Receptor Antagonists as Sleep Aids -- Roles for Orexin/Hypocretin in the Control of Energy Balance and Metabolism -- Orexin and Central Modulation of Cardiovascular and Respiratory Function -- Role of the Orexin/Hypocretin System in Stress-Related Psychiatric Disorders -- The Role of Orexins/Hypocretins in Alcohol Use and Abuse -- A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?- Hypocretin/Orexin and Plastic Adaptations Associated with Drug Abuse.
520	3		_aThis issue of Current Topics in Behavioral Neuroscience focuses on the neuropeptide orexin (hypocretin) and brings together scientists from around the world who will provide a timely discussion of how this peptide regulates behavior. This is a fast-moving field, and with the incorporation of novel technologies, new breakthroughs are likely to continue. For example, the use of optogenetic approaches has enabled the identification of the role of orexin-containing neurons in arousal states, critical for higher order functioning. From a clinical perspective, genetic polymorphisms in hypocretin/orexin and orexin receptors are implicated in a number of psychiatric disorders. In addition, advanced clinical trials are currently underway for orexin receptor antagonists in the treatment of insomnia and sleep disorders. We aim to capture a broad audience of basic scientists and clinicians.
650		7	_aNeuropsicología _2embne _0(OCoLC)fst01036493 _0 _9141010
700	1		_aLawrence, Andrew J. _c(Professor of behavioural neuroscience), _eeditor literario
700	1		_aLecea, Luis de, _eeditor literario
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-57535-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988			_aEBOOK, asignarmaterias, EBSPRINGER_2017D
998			_b02/2018 _dz _e- _zSI
999			_c96101 _d96101 _x1